RGT-028

N/A

Report date: 2022/03/29 17:56:59
NME

Base Information

Drug NameRGT-028
Drug Alias NameRGT-028
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlucagon-like peptide 1 receptor modulators
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsEndocrine System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQILU Regor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesQILU Regor Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsEndocrine System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A